James Vollins's Net Worth

$289 Thousand

Estimate Recalculated Sep 8, 2024 07:35PM EST

Who is James Vollins?

James Vollins does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include BIODELIVERY SCIENCES INTERNATIONAL INC, and Eiger BioPharmaceuticals, Inc..

SEC CIK

James Vollins's CIK is 0001757833

Past Insider Trading and Trends

2020 was James Vollins's most active year for acquiring shares with 6 total transactions. James Vollins's most active month to acquire stocks was the month of December. 2022 was James Vollins's most active year for disposing of shares, totalling 11 transactions. James Vollins's most active month to dispose stocks was the month of February. 2022 saw James Vollins paying a total of $249,999.24 for 443,522 shares, this is the most they've acquired in one year. In 2019 James Vollins cashed out on 59,650 shares for a total of $181,634.25, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BIODELIVERY SCIENCES INTERNATIONAL INC No price found

See Remarks

James Vollins used to own units in Common Stock but no longer holds any shares there.acquired a total of 125,698 shares in BIODELIVERY SCIENCES INTERNATIONAL INC at a cost of $290,886.40, James also disposed a total of 125,698 shares of BIODELIVERY SCIENCES INTERNATIONAL INC equalling to $579,710.26.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 22
Form 4
-100.00%
-28.41K
$3.62
-$102,879.12
0
Scheduled
Feb 4
Form 4
∞
28.41K
—
—
28.41K
Jan 27 - Jan 31
Form 4
—
0
—
—
0
Jan 17
Form 4
-100.00%
-12.14K
$4.03
-$48,908.19
0
Scheduled
Feb 4 - Feb 8
Form 4
∞
12.14K
—
—
12.14K
Jan 29 - Feb 1
Form 4
—
0
—
—
0
Jan 27
Form 4
—
0
$3.97
-$30,015.10
0
Dec 14 - Dec 16
Form 4
—
0
$4.25
-$15,166.20
0
May 21
Form 4
-100.00%
-3.83K
$3.50
-$13,415.50
0
Mar 16
Form 4
∞
3.83K
—
—
3.83K
Jan 31
Form 4
—
0
—
—
0
Jan 29
Form 4
—
0
$4.78
-$78,439.75
0
Nov 15
Form 4
—
0
—
—
0
Jan 31
Form 4
—
0
—
—
0
Nov 5
Form 3
—
0
—
—
0
No matching records found

Eiger BioPharmaceuticals, Inc. (EIGR) No price found

General Counsel

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 30
Form 3
—
0
—
—
0
No matching records found